Jefferies Downgrades Sanofi (SNY) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Tesla acquires AI hardware company for up to $2 billion in stock
BofA/Merrill Lynch Downgrades Sanofi-Aventis (SNY) to Neutral on CEO Removal
October 29, 2014 8:47 AM EDTBofA/Merrill Lynch downgraded Sanofi-Aventis (NYSE: SNY) from Buy to Neutral with a price target of $48.00 after the announcement that it has unanimously voted to remove Chris Viehbacher from his position as CEO.
Analyst Graham Parry said the news is negative for several... More
Barclays Downgrades Sanofi (SNY) to Equalweight
October 29, 2014 8:35 AM EDTBarclays downgraded Sanofi (NYSE: SNY) from Overweight to Equalweight.
For an analyst ratings summary and ratings history on Sanofi click here. For more ratings news on Sanofi click here.
Shares of Sanofi closed at $48.07 yesterday.
... MoreDeutsche Bank Downgrades Sanofi (SNY) to Hold
October 29, 2014 8:34 AM EDTDeutsche Bank downgraded Sanofi (NYSE: SNY) from Buy to Hold with a price target of EUR 78 from EUR 93.
Analyst Mark Clark said, "We have been BUYers of Sanofi since we initiated coverage in 2009 but now feel it is time to... More
Sanofi (SNY) Terminates CEO Viehbacher
October 29, 2014 6:00 AM EDTThe Board of Directors held a meeting Wednesday, October 29 at 8am and decided unanimously to remove Christopher A. Viehbacher as Chief Executive Officer of Sanofi (NYSE: SNY). As a consequence Christopher A. Viehbacher resigned as a director of Sanofi.
The Board of... More
